1. Home
  2. SURG vs CRIS Comparison

SURG vs CRIS Comparison

Compare SURG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

N/A

Current Price

$0.15

Market Cap

6.4M

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$0.83

Market Cap

2.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SURG
CRIS
Founded
2006
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
2.0M
IPO Year
2019
2000

Fundamental Metrics

Financial Performance
Metric
SURG
CRIS
Price
$0.15
$0.83
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$3.75
★ $42.67
AVG Volume (30 Days)
★ 13.2M
137.0K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
24.69
★ 91.57
EPS
★ N/A
N/A
Revenue
★ $56,962,920.00
$9,898,000.00
Revenue This Year
$14.11
N/A
Revenue Next Year
$23.23
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 31.50
52 Week Low
$0.13
$0.18
52 Week High
$3.14
$6.74

Technical Indicators

Market Signals
Indicator
SURG
CRIS
Relative Strength Index (RSI) 40.38 19.84
Support Level $0.15 $0.80
Resistance Level $0.23 $1.04
Average True Range (ATR) 0.02 0.09
MACD 0.00 0.05
Stochastic Oscillator 15.13 10.00

Price Performance

Historical Comparison
SURG
CRIS

About SURG SurgePays Inc.

Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: